Guidewires Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

September 2024 | 190 pages | ID: GB930E4174FFEN
Global Market Insights

US$ 4,365.00 US$ 4,850.00 -10 %
Offer valid until June 30, 2025!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Global Guidewires Market was valued at USD 1.3 billion in 2023 and is expected to grow at a CAGR of 3% from 2024 to 2032. This growth is driven by the rising incidence of chronic conditions, increasing minimally invasive surgical procedures, and the availability of advanced technologies in guidewires. Innovations in guidewire technology, such as the use of nitinol and stainless steel materials and the development of hydrophilic and hydrophobic coatings, are boosting market expansion. These advancements improve guidewire durability, flexibility, and performance, making procedures more efficient. Steerable and coated guidewires also offer reduced friction, improving navigation through complex vascular pathways and enhancing procedural success rates.
The global trend toward minimally invasive surgery is a key factor driving the demand for guidewires. These surgeries offer benefits such as shorter recovery times, reduced hospital stays, and a lower risk of complications compared to traditional procedures. Guidewires are essential for the precise placement of catheters and medical devices, making them indispensable in various medical specialties. By material, the market is segmented into nitinol, stainless steel, hybrid, and other materials.
Nitinol guidewires accounted for a 33.4% market share in 2023 due to their flexibility, elasticity, and kink resistance, which allow them to navigate complex vascular paths with ease and reduce complications. By coating, the market is split into coated and non-coated segments. Coated guidewires held a dominant market share of 81.4% in 2023, owing to their ability to reduce friction and provide better tactile feedback, leading to improved control and maneuverability during procedures. The coronary guidewires segment dominated the market with a 41.8% share in 2023, driven by the increasing prevalence of coronary artery diseases and the growing demand for minimally invasive treatments.
The 0.035-inch guidewires segment, valued at USD 511 million in 2023, is highly popular due to its versatility and wide application in various medical procedures. The 180 cm guidewires segment, valued at USD 368.2 million, is widely used in interventional procedures due to its durability and ability to navigate tortuous anatomy. By end use, hospitals dominate, projected to reach USD 606.2 million by 2032, thanks to their reliance on guidewires for precise navigation in complex procedures. In North America, the guidewires market was valued at USD 449.6 million in 2023, driven by advanced healthcare infrastructure and the growing aging population.The U.S. market is expected to grow at a CAGR of 1.9%, reaching USD 469.2 million by 2032.
Report Content

CHAPTER 1 METHODOLOGY & SCOPE

1.1 Market scope & definitions
1.2 Research design
  1.2.1 Research approach
  1.2.2 Data collection methods
1.3 Base estimates & calculations
  1.3.1 Base year calculation
  1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
  1.5.1 Primary sources
  1.5.2 Data mining sources

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Industry 360° synopsis

CHAPTER 3 INDUSTRY INSIGHTS

3.1 Industry ecosystem analysis
3.2 Industry impact forces
  3.2.1 Growth drivers
    3.2.1.1 Rising adoption of minimally invasive surgical procedures
    3.2.1.2 Increasing number of lifestyle disorders in developing countries
    3.2.1.3 Various reimbursement policies in developed countries
    3.2.1.4 Growing geriatric population base across the globe
  3.2.2 Industry pitfalls & challenges
    3.2.2.1 High cost of guidewires
    3.2.2.2 Dearth of skilled professionals in developing economies
    3.2.2.3 Risks associated with guidewires
3.3 Growth potential analysis
3.4 Reimbursement scenario
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis

CHAPTER 4 COMPETITIVE LANDSCAPE, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

CHAPTER 5 MARKET ESTIMATES AND FORECAST, BY MATERIAL, 2021 – 2032 ($ MN & UNITS)

5.1 Key trends
5.2 Nitinol
5.3 Stainless steel
5.4 Hybrid
5.5 Other materials

CHAPTER 6 MARKET ESTIMATES AND FORECAST, BY COATING, 2021 – 2032 ($ MN)

6.1 Key trends
6.2 Coated
  6.2.1 Hydrophilic coating
  6.2.2 Anti-thrombogenic/Heparin coating
  6.2.3 Hydrophobic coating
  6.2.4 Silicone coating
  6.2.5 Tetrafluoroethylene (TFE) coating
6.3 Non-coated

CHAPTER 7 MARKET ESTIMATES AND FORECAST, BY APPLICATION, 2021 – 2032 ($ MN & UNITS)

7.1 Key trends
7.2 Coronary guidewires
7.3 Peripheral guidewires
7.4 Urology guidewires
7.5 Neurovascular guidewires
7.6 Other applications

CHAPTER 8 MARKET ESTIMATES AND FORECAST, BY DIAMETER, 2021 – 2032 ($ MN & UNITS)

8.1 Key trends
8.2 0.014 inch
8.3 0.018 inch
8.4 0.025 inch
8.5 0.032 inch
8.6 0.035 inch
8.7 0.038 inch

CHAPTER 9 MARKET ESTIMATES AND FORECAST, BY LENGTH, 2021 – 2032 ($ MN & UNITS)

9.1 Key trends
9.2 80 cm
9.3 120 cm
9.4 145 cm
9.5 150 cm
9.6 180 cm
9.7 260 cm
9.8 300 cm
9.9 450 cm
9.10 Other lengths

CHAPTER 10 MARKET ESTIMATES AND FORECAST, BY END-USE, 2021 – 2032 ($ MN)

10.1 Key trends
10.2 Hospitals
10.3 Ambulatory surgical centers
10.4 Research laboratories
10.5 Other end-users

CHAPTER 11 MARKET ESTIMATES AND FORECAST, BY REGION, 2021 – 2032 ($ MN)

11.1 Key trends
11.2 North America
  11.2.1 U.S.
  11.2.2 Canada
11.3 Europe
  11.3.1 Germany
  11.3.2 UK
  11.3.3 France
  11.3.4 Spain
  11.3.5 Italy
  11.3.6 Russia
  11.3.7 Switzerland
  11.3.8 Netherlands
  11.3.9 Rest of Europe
11.4 Asia Pacific
  11.4.1 China
  11.4.2 Japan
  11.4.3 India
  11.4.4 Australia
  11.4.5 Singapore
  11.4.6 Malaysia
  11.4.7 Rest of Asia Pacific
11.5 Latin America
  11.5.1 Brazil
  11.5.2 Mexico
  11.5.3 Argentina
  11.5.4 Colombia
  11.5.5 Peru
  11.5.6 Rest of Latin America
11.6 Middle East and Africa
  11.6.1 South Africa
  11.6.2 Saudi Arabia
  11.6.3 UAE
  11.6.4 Egypt
  11.6.5 Rest of Middle East and Africa

CHAPTER 12 COMPANY PROFILES

12.1 Abbott Laboratories
12.2 AngioDynamics Inc.
12.3 Asahi Intecc Co. Ltd
12.4 B. Braun Melsungen AG
12.5 Boston Scientific Corporation
12.6 Becton, Dickinson and Company
12.7 Cook Group Incorporated
12.8 Cardinal Healthcare Inc.
12.9 C.R. Bard Inc.
12.10 Medtronic plc
12.11 Merit Medical Inc
12.12 Olympus Corporation
12.13 Stryker Corporation
12.14 Terumo Corporation
12.15 Teleflex Incorporated


More Publications